Investor Relations

For press releases prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Theravance, Inc. Investor Relations Press Releases.


Press Releases
Date Title and Summary View
Sep 9, 2014 SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 09/09/14 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today provided a product update for VIBATIV® (telavancin), the Company's proprietary FDA-approved bactericidal, once-daily, injectable lipoglycopeptide antibiotic. The Company detailed plans for addit...
Sep 8, 2014 SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 09/08/14 -- Theravance Biopharma (NASDAQ: TBPH), through its US operating subsidiary, Theravance Biopharma US, Inc., today announced positive top-line results from its Phase 2b dose-ranging study of TD-4208, an investigational long-acting muscarinic antagonist (LAMA) in development for the treatment ...
Aug 21, 2014 SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 08/21/14 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) announced today that Rick E Winningham, Theravance Biopharma's Chief Executive Officer, is scheduled to present at the following investor conferences in September 2014: Baird 2014 Health Care Conference The New York Palace, N...
Aug 13, 2014 SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 08/13/14 -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today reported financial results for the second quarter 2014, and provided a corporate update. Revenue for the second quarter of 2014 was $3.0 million. Net loss for the second quarter of 2014 was $58.2 mil...
Jun 2, 2014 SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 06/02/14 -- Theravance, Inc. (NASDAQ: THRX) ("Theravance") and Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") today announced the completion of the separation of Theravance Biopharma, Inc., the research and development-based biopharmaceutical business, from Theravance, Inc. to form two...
Page:
1
Add to Briefcase = add release to Briefcase
By clicking on the link below, you will leave www.theravance.com.
CancelContinue
Form content here please :)